BIOMERICA INC Lease, Cost
BIOMERICA INC (BMRA) reported Lease, Cost of $374.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-31
- BIOMERICA INC lease, cost for the quarter ending 2026-05-31 was $98.00K, a 3.16% increase year-over-year.
- BIOMERICA INC lease, cost for the quarter ending 2026-02-28 was $94.00K, a 0.00% change year-over-year.
- BIOMERICA INC lease, cost for the quarter ending 2025-11-30 was $93.00K, a 0.00% change year-over-year.
- BIOMERICA INC lease, cost for the quarter ending 2025-08-31 was $91.00K, a 1.09% decline year-over-year.
- BIOMERICA INC lease, cost for fiscal 2026 was $374.00K, a 0.27% decline from fiscal 2025.
- BIOMERICA INC lease, cost for fiscal 2025 was $375.00K, a 0.79% decline from fiscal 2024.
- BIOMERICA INC lease, cost for fiscal 2024 was $378.00K, a 5.59% increase from fiscal 2023.
- BIOMERICA INC lease, cost for fiscal 2023 was $358.00K, a 0.28% increase from fiscal 2022.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-05-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $192.00K derived: sum of 2 quarters · filed 2026-08-31 | $285.00K derived: sum of 3 quarters · filed 2026-08-31 | $374.00K 10-K · filed 2026-08-31 |
| 2026-02-28 | $94.00K 10-Q · filed 2026-04-13 | $187.00K derived: sum of 2 quarters · filed 2026-04-13 | $276.00K 10-Q · filed 2026-04-13 | $373.00K derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-11-30 | $93.00K 10-Q · filed 2026-01-14 | $185.00K 10-Q · filed 2026-01-14 | $279.00K derived: sum of 3 quarters · filed 2026-08-31 | $373.00K derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-08-31 | $91.00K 10-Q · filed 2025-10-14 | $186.00K derived: sum of 2 quarters · filed 2026-08-31 | $280.00K derived: sum of 3 quarters · filed 2026-08-31 | $373.00K derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-05-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $189.00K derived: sum of 2 quarters · filed 2026-08-31 | $282.00K derived: sum of 3 quarters · filed 2026-08-31 | $375.00K 10-K · filed 2026-08-31 |
| 2025-02-28 | $94.00K 10-Q · filed 2026-04-13 | $187.00K derived: sum of 2 quarters · filed 2026-04-13 | $280.00K 10-Q · filed 2026-04-13 | $374.00K derived: sum of 4 quarters · filed 2026-04-13 |
| 2024-11-30 | $93.00K 10-Q · filed 2026-01-14 | $185.00K 10-Q · filed 2026-01-14 | $280.00K derived: sum of 3 quarters · filed 2026-01-14 | $379.00K derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-08-31 | $92.00K 10-Q · filed 2025-10-14 | $187.00K derived: sum of 2 quarters · filed 2025-10-14 | $286.00K derived: sum of 3 quarters · filed 2025-10-14 | $377.00K derived: sum of 4 quarters · filed 2025-10-14 |
| 2024-05-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $194.00K derived: sum of 2 quarters · filed 2025-08-29 | $285.00K derived: sum of 3 quarters · filed 2025-08-29 | $378.00K 10-K · filed 2025-08-29 |
| 2024-02-29 | $99.00K 10-Q · filed 2024-04-12 | $99.00K 10-Q · filed 2025-04-14 | $283.00K 10-Q · filed 2025-04-14 | $376.00K derived: sum of 4 quarters · filed 2025-01-14 |
| 2023-11-30 | $91.00K 10-Q · filed 2025-01-14 | $183.00K 10-Q · filed 2025-01-14 | $277.00K derived: sum of 3 quarters · filed 2025-01-14 | $366.50K derived: sum of 4 quarters · filed 2025-01-14 |
| 2023-08-31 | $96.00K 10-Q · filed 2024-10-15 | $186.00K derived: sum of 2 quarters · filed 2024-10-15 | $275.50K derived: sum of 3 quarters · filed 2024-10-15 | $364.50K derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $179.50K derived: sum of 2 quarters · filed 2024-08-28 | $268.50K derived: sum of 3 quarters · filed 2024-08-28 | $358.00K 10-K · filed 2024-08-28 |
| 2023-02-28 | $89.50K 10-Q · filed 2024-04-12 | $178.50K derived: sum of 2 quarters · filed 2024-04-12 | $268.00K 10-Q · filed 2024-04-12 | |
| 2022-11-30 | $89.00K 10-Q · filed 2024-01-16 | $179.00K 10-Q · filed 2024-01-16 | ||
| 2022-08-31 | $92.00K 10-Q · filed 2023-10-12 | |||
| 2022-05-31 | $357.00K 10-K · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |